Zoetis Inc (XTER:ZOE)
€ 161.04 -7.48 (-4.47%) Market Cap: 72.99 Bil Enterprise Value: 77.63 Bil PE Ratio: 34.28 PB Ratio: 15.16 GF Score: 96/100

Zoetis Inc at Bank of America Merrill Lynch Animal Health Summit Transcript

Feb 25, 2019 / 08:05PM GMT
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

Joining us is Glenn David, CFO of Zoetis. We're gonna start with just the fireside chat, and then open up for questions. So thank you for joining us.

Glenn C. David
Zoetis Inc. - Executive VP & CFO

Thank you for having me.

Questions & Answers

Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

So just high level at the start, can you review 2018? It was a little bit of an eventful year, had a lot happened, so let's just go through the story over course of the year and where you ended.

Glenn C. David
Zoetis Inc. - Executive VP & CFO

Absolutely. So 2018 was a great year for us at Zoetis. So when you start with the top line, we're able to grow revenue at 10%. And part of that contribution was 2% from Abaxis, which was one of the big events that we had in 2018. With the acquisition of Abaxis, we're very excited about. Overall, though, our organic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot